Literature DB >> 10092164

Hypothalamo-pituitary-adrenal axis and growth hormone axis in patients with rheumatoid arthritis.

H Demir1, F Keleştimur, M Tunç, M Kirnap, Y Ozügül.   

Abstract

Rheumatoid arthritis (RA) is a systemic disease and is associated with cytokines (IL-1, IL-6, TNF-alpha) production. There is little information on hypothalamo-pituitary-adrenal (HPA) axis and growth hormone (GH) axis in the patients with RA. We have, therefore, investigated these systems in twenty patients with confirmed RA. Ten of the patients had active and 10 patients remitted RA. Serum cortisol, ACTH and GH levels were measured in the basal state and after insulin induced hypoglycaemia. Cortisol, adrenocorticotropic hormone (ACTH) and GH responses were impaired in 65%, 85% and 30% of the patients, respectively. The basal and peak hormone levels were similar between the patients with active RA and the patients in remission. These findings indicate that there is an impairment in HPA and GH axis in patients with active and remitted RA. The site of this impairment is probably hypothalamus and/or pituitary gland.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10092164     DOI: 10.1080/03009749950155779

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  9 in total

Review 1.  Neuroendocrine-immune aspects of accelerated aging in rheumatoid arthritis.

Authors:  Peter Härle; Rainer H Straub
Journal:  Curr Rheumatol Rep       Date:  2005-10       Impact factor: 4.592

2.  Cardiac autonomic functions in children with familial Mediterranean fever.

Authors:  Murat Şahin; Mustafa Kır; Balahan Makay; Pembe Keskinoğlu; Elçin Bora; Erbil Ünsal; Nurettin Ünal
Journal:  Clin Rheumatol       Date:  2014-06-15       Impact factor: 2.980

Review 3.  Growth hormone in musculoskeletal pain states.

Authors:  Robert Bennett
Journal:  Curr Rheumatol Rep       Date:  2004-08       Impact factor: 4.592

4.  Renal clearance and daily excretion of cortisol and adrenal androgens in patients with rheumatoid arthritis and systemic lupus erythematosus.

Authors:  R H Straub; C Weidler; B Demmel; M Herrmann; F Kees; M Schmidt; J Schölmerich; J Schedel
Journal:  Ann Rheum Dis       Date:  2004-08       Impact factor: 19.103

5.  Impaired hypothalamo-pituitary-adrenal axis in patients with ankylosing spondylitis.

Authors:  L Kebapcilar; O Bilgir; A Alacacioglu; Y Yildiz; A Taylan; R Gunaydin; A Yuksel; B Karaca; I Sari
Journal:  J Endocrinol Invest       Date:  2009-07-20       Impact factor: 4.256

Review 6.  Annexin-A1: a pivotal regulator of the innate and adaptive immune systems.

Authors:  F D'Acquisto; M Perretti; R J Flower
Journal:  Br J Pharmacol       Date:  2008-07-21       Impact factor: 8.739

Review 7.  Growth hormone in musculoskeletal pain states.

Authors:  Robert Bennett
Journal:  Curr Pain Headache Rep       Date:  2005-10

8.  Diurnal secretion of growth hormone, cortisol, and dehydroepiandrosterone in pre- and perimenopausal women with active rheumatoid arthritis: a pilot case-control study.

Authors:  Marc R Blackman; Ranganath Muniyappa; Mildred Wilson; Barbara E Moquin; Howard L Baldwin; Kelli A Wong; Christopher Snyder; Michael Magalnick; Shaan Alli; James Reynolds; Seth M Steinberg; Raphaela Goldbach-Mansky
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

Review 9.  Neural immune pathways and their connection to inflammatory diseases.

Authors:  Farideh Eskandari; Jeanette I Webster; Esther M Sternberg
Journal:  Arthritis Res Ther       Date:  2003-09-23       Impact factor: 5.156

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.